A threat actor exploited a critical vulnerability in Triofox to obtain remote access to a vulnerable server and then achieve code execution.
Results from the PATHFINDER 2 trial of Grail's blood test for multiple cancers have shown greater efficacy and a lower rate of false alarms than in an earlier trial of the technology. The Galleri ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback